Literature DB >> 11710921

The differentiation and function of myofibroblasts is regulated by mast cell mediators.

J Gailit1, M J Marchese, R R Kew, B L Gruber.   

Abstract

Myofibroblasts are fibroblasts that express certain features of smooth muscle differentiation. Increased numbers of myofibroblasts and mast cells are frequently found together in a wide variety of settings, such as normal wound repair and scleroderma skin, which suggests that mediators produced by the mast cells could play a role in the regulation of myofibroblast differentiation and function. We used a human mast cell line, HMC-1, to determine if mast cells can induce normal human dermal fibroblasts to differentiate into functional myofibroblasts in vitro. We monitored the differentiation process by assaying two properties of the myofibroblast phenotype: expression of alpha-smooth muscle actin and functional capacity to contract a collagen matrix. In both a simple coculture system and in a skin-equivalent culture system, HMC-1 cells induced alpha-smooth muscle actin expression by fibroblasts. HMC-1 cells also stimulated fibroblast contraction of collagen gels, and the relative amount of contraction was dependent upon the number of HMC-1 cells present. To characterize the individual contributions made by specific mast cell products, we examined the effects of histamine, tumor necrosis factor alpha, and tryptase. Histamine induced a clear increase in alpha-smooth muscle actin expression, but it did not appear to stimulate fibroblast contraction. Tumor necrosis factor alpha had no effect in either assay. Purified human tryptase induced alpha-smooth muscle actin expression, and blocking the proteolytic activity of tryptase with specific inhibitors reduced that response. Tryptase inhibitors also eliminated the ability of HMC-1 cells to stimulate fibroblast contraction, suggesting that tryptase secreted by the HMC-1 cells may be one of the active mast cell mediators.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710921     DOI: 10.1046/j.1523-1747.2001.15211.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  49 in total

Review 1.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

Authors:  Scott P Levick; Giselle C Meléndez; Eric Plante; Jennifer L McLarty; Gregory L Brower; Joseph S Janicki
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

2.  The role of mast cells in wound healing.

Authors:  Michael F Y Ng
Journal:  Int Wound J       Date:  2010-02       Impact factor: 3.315

3.  Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1.

Authors:  Lucy Woodman; Salman Siddiqui; Glenn Cruse; Amanda Sutcliffe; Ruth Saunders; Davinder Kaur; Peter Bradding; Christopher Brightling
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 4.  Mast cell activity in the healing wound: more than meets the eye?

Authors:  Brian C Wulff; Traci A Wilgus
Journal:  Exp Dermatol       Date:  2013-06-27       Impact factor: 3.960

Review 5.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

6.  Do laser and led phototherapies influence mast cells and myofibroblasts to produce collagen?

Authors:  Isabele Cardoso Vieira De Castro; Clarissa Araújo Gurgel Rocha; Aguida Cristina Gomes Henriques; Ana Paula Cavalcanti de Sousa; Márcio Vieira Lisboa; Drielli da Rocha Sotero; Antônio Luiz Barbosa Pinheiro; Patrícia Ramos Cury; Jean Nunes Dos Santos
Journal:  Lasers Med Sci       Date:  2014-02-20       Impact factor: 3.161

Review 7.  The Importance of Mast Cells in Dermal Scarring.

Authors:  Traci A Wilgus; Brian C Wulff
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

Review 8.  Targeting Inflammatory Cytokines and Extracellular Matrix Composition to Promote Wound Regeneration.

Authors:  Carlos Zgheib; Junwang Xu; Kenneth W Liechty
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

Review 9.  Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.

Authors:  Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

Review 10.  Pharmacotherapy of systemic sclerosis.

Authors:  Arnold E Postlethwaite; L Jeff Harris; Syed H Raza; Swapna Kodura; Titilola Akhigbe
Journal:  Expert Opin Pharmacother       Date:  2010-04       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.